The BATTLE to personalize lung cancer prevention through reverse migration. - Wikidata - wikimedia - TriplyDB

The BATTLE to personalize lung cancer prevention through reverse migration.

The BATTLE to personalize lung cancer prevention through reverse migration.

http://www.wikidata.org/entity/Q35208501

about

Biomarker-Guided Adaptive Trial Designs in Phase II and Phase III: A Methodological Review Oral premalignancy: the roles of early detection and chemoprevention Pulmonary adenocarcinoma: a renewed entity in 2011 Acquisition and processing of endobronchial ultrasound-guided transbronchial needle aspiration specimens in the era of targeted lung cancer chemotherapy.Field cancerization in non-small cell lung cancer: implications in disease pathogenesis.Precision medicine clinical trials: defining new treatment strategies.Genes suppressed by DNA methylation in non-small cell lung cancer reveal the epigenetics of epithelial-mesenchymal transition Into the eye of the storm: breast cancer's somatic mutation landscape points to DNA damage and repair Volumetric Tumor Response and Progression in EGFR-mutant NSCLC Patients Treated with Erlotinib or Gefitinib G-protein coupled receptor family C, group 5, member A (GPRC5A) expression is decreased in the adjacent field and normal bronchial epithelia of patients with chronic obstructive pulmonary disease and non-small-cell lung cancer.Tumor volume decrease at 8 weeks is associated with longer survival in EGFR-mutant advanced non-small-cell lung cancer patients treated with EGFR TKI.Personalizing lung cancer prevention through a reverse migration strategy.Characterizing the molecular spatial and temporal field of injury in early-stage smoker non-small cell lung cancer patients after definitive surgery by expression profiling.Ewing's sarcoma: overcoming the therapeutic plateau.Transcriptomic architecture of the adjacent airway field cancerization in non-small cell lung cancer.Lung cancer chemoprevention: difficulties, promise and potential agents?Biomarkers and sustainable innovation in cardiovascular drug development: lessons from near and far afield.Adaptive Clinical Trials: Overview of Early-Phase Designs and Challenges.The dynamics of gene expression changes in a mouse model of oral tumorigenesis may help refine prevention and treatment strategies in patients with oral cancer.TBX2 subfamily suppression in lung cancer pathogenesis: a high-potential marker for early detection.Identification of key genes and long non‑coding RNAs in celecoxib‑treated lung squamous cell carcinoma cell line by RNA‑sequencing.

P2860

Q26766584-A16062D8-B69B-459F-A1B6-84F3ACE5E91F Q27693327-BAE1562A-0265-492C-9C1A-E48A31D4AD3F Q28395348-FDF2E51C-6BFD-441D-ACCB-9FC25588BB9A Q30513309-2EAB0560-1E29-40F7-9943-723F0714364F Q34272221-DE053E94-1555-4568-A558-F2F28B96217D Q34794577-E8D3544A-32FF-43AB-A978-5003A69CCEE0 Q34984574-B973EC8C-BF9F-41EF-B69D-2200B656DDF0 Q36311747-B47893AE-70D7-425F-9EB9-77FB0E67AC35 Q36553854-C7760AC8-BB37-487D-8E9A-A1524F4D883E Q36755508-C697903E-409A-4545-AC7E-7F9B03EE061C Q37021940-3EA65C11-DE0A-4FAC-9C83-74D4FD418911 Q37080513-7426055B-1515-4A92-9CA5-A7F4272F812B Q37175654-CD7A9803-9AC3-4243-AC94-A76208C12B9C Q37487126-7DB55F66-A07B-4DC9-BFB5-8EF0D8CF5815 Q37696458-8248D69A-E37B-4DAA-8133-902250375C94 Q38061199-ABCAC927-1E69-4DB6-89FC-B0D1A011B7DA Q38091371-870FE11D-1D95-4360-89DD-86FDD15ACD90 Q38697445-D3EA56B0-E382-4870-AEB1-9A1E3FCB60CF Q41667207-64BB68E9-69CE-40A3-8C6B-044591006D4C Q42366611-D4FFC697-F926-4837-B32B-B02F70735F70 Q52670086-01EEA67C-D38B-45A9-9873-B28DE5DEFC42

P2860

The BATTLE to personalize lung cancer prevention through reverse migration.

http://www.wikidata.org/entity/Q35208501

description

2011 nî lūn-bûn

@nan

2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

The BATTLE to personalize lung cancer prevention through reverse migration.

@ast

The BATTLE to personalize lung cancer prevention through reverse migration.

@en

type

label

The BATTLE to personalize lung cancer prevention through reverse migration.

@ast

The BATTLE to personalize lung cancer prevention through reverse migration.

@en

prefLabel

The BATTLE to personalize lung cancer prevention through reverse migration.

@ast

The BATTLE to personalize lung cancer prevention through reverse migration.

@en

P1433

Q35208501-1284E7E0-CC0E-4EB3-9A5D-74CD317C7208

P1476

Q35208501-ED4AB248-CE5F-482D-85D9-87A95C1EFFEE

P2093

Q35208501-55812DFB-FAEF-47FB-96D7-8C560DB2EE68

Q35208501-70DFDD29-386E-43B5-A214-FB12E92ADB20

Q35208501-84989A96-6F15-4A99-AF82-9DA7F80F480D

Q35208501-BEC38BEC-7BA6-47A3-AE63-4C73BEB75CFB

Q35208501-F3FE06A2-4EA9-477B-8854-C6A9248F6171

P2860

Q35208501-001898BF-04FF-46BB-A515-0DF8FEFBFD35

Q35208501-0018EDD1-6CAA-4709-ADFE-A04BAE0878A5

Q35208501-01A40C5A-1907-41D6-819E-3F3124320F4E

Q35208501-027F791E-3441-4715-8F71-86160C674D90

Q35208501-08F2E626-2466-4483-A4A5-5D457811265A

Q35208501-0AC03A5F-891E-4D1B-B033-A49ECC2B18A8

Q35208501-0D46D0D1-1187-49F9-809E-7B1A5A953C0E

Q35208501-0E0C66F1-9C7D-485F-A68B-30B09E4401E5

Q35208501-0E82DA69-A036-4F0F-80CE-D6C3E385FC10

Q35208501-0E84A398-1803-419D-BDE9-A4277698A62D

P304

Q35208501-02762827-58BE-458C-85C1-B68FE97D108A

P31

Q35208501-096B5F7B-110A-4A92-9F11-9B221FE19D56

P356

Q35208501-62A802CB-FBB4-4332-905C-7E93879161D9

P433

Q35208501-BCA4FD4C-B739-4126-B32B-769B183146EE

P478

Q35208501-C5E135A2-6A68-499E-A9E1-0B96A8996A5D

P50

Q35208501-384DD08F-2AEA-4589-8877-648B103FDABB

P577

Q35208501-C5EBF38D-7526-45FE-96DE-7E9EB10D8F3E

P5875

Q35208501-32B281CA-3CFF-4622-98E6-960F18344F71

P698

Q35208501-BC04C653-F402-42A9-AE71-CF408CB376CB

P932

Q35208501-AEDDF2C2-74F8-49C8-85CF-9BCF766E6A4E

P356

1940-6207.CAPR-11-0232

P1433

Cancer Prevention Research

P1476

The BATTLE to personalize lung cancer prevention through reverse migration.

@en

P2093

Carol J Farhangfar

http://www.w3.org/2001/XMLSchema#string

Edward S Kim

http://www.w3.org/2001/XMLSchema#string

J Jack Lee

http://www.w3.org/2001/XMLSchema#string

Kathryn A Gold

http://www.w3.org/2001/XMLSchema#string

Waun Ki Hong

http://www.w3.org/2001/XMLSchema#string

P2860

Somatic mutations affect key pathways in lung adenocarcinoma

Tumours with PI3K activation are resistant to dietary restriction

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.

Effective use of PI3K and MEK inhibitors to treat mutant Kras G12D and PIK3CA H1047R murine lung cancers.

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.

Mutations in the DDR2 kinase gene identify a novel therapeutic target in squamous cell lung cancer.

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer

A randomized trial of aspirin to prevent colorectal adenomas

P304

962-972

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1940-6207.CAPR-11-0232

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Ignacio I Wistuba

P577

2011-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51471789

http://www.w3.org/2001/XMLSchema#string

P698

21733820

http://www.w3.org/2001/XMLSchema#string

P932

3171137

http://www.w3.org/2001/XMLSchema#string